Covista Inc. (CVSA)
NYSE:CVSA
Want to see CVSA full AI Analyst Report?
CVSA Stock Chart & Stats
$117.91
-$0.04(-0.04%)
At close: 4:00 PM EST
$117.91
-$0.04(-0.04%)
Day’s Range― - ―
52-Week Range$86.97 - $156.26
Previous CloseN/A
VolumeN/A
Average Volume (3M)292.32K
Market Cap
$4.49B
Enterprise Value$4.60B
Total Cash (Recent Filing)$148.84M
Total Debt (Recent Filing)$736.29M
Price to Earnings (P/E)18.8
Beta0.58
Next Earnings
Aug 06, 2026EPS Estimate
1.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.02
Shares Outstanding34,030,888
10 Day Avg. Volume279,311
30 Day Avg. Volume292,316
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)3.29
Price to Sales (P/S)2.64
P/FCF Ratio16.41
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue2.41
Enterprise Value/Gross Profit4.20
Enterprise Value/Ebitda10.67
Forecast
1Y Price Target
$156.25Price Target Upside32.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)8.06
Revenue Forecast (FY)$1.94B
Bulls Say, Bears Say
Bulls Say
Raised Guidance And Sustained Revenue GrowthManagement raised FY26 revenue guidance to $1.93–$1.945B, signaling durable demand and execution across institutions. Higher guided top-line growth provides multi-quarter revenue visibility that supports reinvestment in campuses, programs and technology partnerships essential for long-term expansion.
Healthy And Expanding Profitability MarginsSustained high gross and EBITDA margins, plus improving net income, indicate structural cost advantages and pricing power in core programs. Margin expansion potential (management targets +100bps) suggests operating leverage from enrollment scale and program mix will help sustain cash generation over the medium term.
Stronger Balance Sheet And Capital AllocationRefinancing extends maturities and reduces interest costs, lowering rollover and liquidity risk. Improved net leverage and active share repurchases demonstrate disciplined capital allocation and provide financial flexibility to fund campus expansion and strategic partnerships without immediate refinancing pressure.
Bears Say
Free Cash Flow VolatilityWhile current FCF is healthy, the recent negative TTM FCF growth and historical volatility reduce predictability of internal funding for expansion and debt reduction. Irregular cash conversion can force higher external financing or slow buybacks and capex if operating conditions deteriorate.
Meaningful Absolute Debt RemainsDespite lower leverage ratios, the company still holds a sizable absolute debt balance that could amplify downside in weaker earnings periods. Higher absolute debt increases sensitivity to cash-flow swings and constrains optionality for M&A or sustained elevated investment without further deleveraging.
Chamberlain Growth And Post‑licensure WeaknessModest Chamberlain enrollment gains and reported softness in post-licensure (RN-to-BSN) demand point to structural limits in a key revenue segment. Slow recovery in this category could temper medium-term top-line expansion and require sustained marketing or product changes to restore higher growth rates.
Covista News
CVSA FAQ
What was Covista Inc.’s price range in the past 12 months?
Covista Inc. lowest stock price was $86.97 and its highest was $156.26 in the past 12 months.
What is Covista Inc.’s market cap?
Covista Inc.’s market cap is $4.49B.
When is Covista Inc.’s upcoming earnings report date?
Covista Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 53 days.
How were Covista Inc.’s earnings last quarter?
Covista Inc. released its earnings results on May 07, 2026. The company reported $1.98 earnings per share for the quarter, beating the consensus estimate of $1.722 by $0.258.
Is Covista Inc. overvalued?
According to Wall Street analysts Covista Inc.’s price is currently Undervalued.
Does Covista Inc. pay dividends?
Covista Inc. pays a Semiannually dividend of $0.18 which represents an annual dividend yield of N/A. See more information on Covista Inc. dividends here
What is Covista Inc.’s EPS estimate?
Covista Inc.’s EPS estimate is 1.92.
How many shares outstanding does Covista Inc. have?
Covista Inc. has 34,030,888 shares outstanding.
What happened to Covista Inc.’s price movement after its last earnings report?
Covista Inc. reported an EPS of $1.98 in its last earnings report, beating expectations of $1.722. Following the earnings report the stock price went up 14.299%.
Which hedge fund is a major shareholder of Covista Inc.?
Currently, no hedge funds are holding shares in CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$156.25 (32.52% Upside)
$156.25 (32.52% Upside)
Blogger Sentiment
Bullish
CVSA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 51.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.05%
12-Months-Change
Fundamentals
Return on Equity
16.62%
Trailing 12-Months
Asset Growth
-1.88%
Trailing 12-Months
Company Description
Covista Inc.
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.
CVSA Company Deck
CVSA Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: enrollment growth across institutions, improved margins (when adjusting for a one-week timing shift), raised revenue and EPS guidance, robust free cash flow, balance sheet improvement, share repurchases, campus expansion plans, and technology/AI initiatives. Near-term headwinds include an $18M timing impact at Walden that masked stronger underlying results, modest absolute enrollment improvement at Chamberlain this quarter (0.5%), continued investment-driven CapEx and strategic spending, and an expected higher effective tax rate. Overall, the positives (organic growth, margin expansion excluding timing, raised guidance, cash generation, and clear remediation at Chamberlain) outweigh the transitory and execution-related challenges noted.View all CVSA earnings summariesCVSA Stock 12 Month Forecast
Average Price Target
$156.25
▲(32.52% Upside)
Technical Analysis
Perdoceo Education
―
Grand Canyon Education
―
Strategic Education
―
Graham Holdings
―
Laureate Education
―
Ownership Overview
2.74% Insiders
38.04% Mutual Funds
22.29% Other Institutional Investors
8.79% Public Companies and
Individual Investors